ARTICLE | Company News
Xenon, Merck deal
April 22, 2013 7:00 AM UTC
Xenon said Merck exercised its option to license exclusive, worldwide rights to small molecules for an undisclosed target to treat cardiovascular disease. Merck received the option under a 2009 deal i...